| Document Date: 2014-10-13 15:47:24
Open Document File Size: 1,90 MBShare Result on Facebook
City Houston / Cut-Off Wilmington / / Company Jakafi / MedImmune / Incyte Corporation / Novartis / Merck / Lilly / Hervé Hoppenot Incyte / Genentech / Bristol-Myers Squibb / / Country United States / / / Event FDA Phase / / Facility MD Anderson Cancer Center / / IndustryTerm biopharmaceutical / pharmaceutical professionals / healthcare / pharmaceutical / treatment of patients with other types of cancer / / MedicalCondition polycythemia vera / blisters / Incyte Corporation Quick Facts Non-small cell lung cancer / breast cancers / cancer / headache / Colorectal cancer / painful skin rash / aches / shortness of breath / Multiple cancers / chills / nausea / colorectal cancers / rare blood cancer / polycythemia vera myelofibrosis / primary myelofibrosis / INCY Multiple cancers / fever / vomiting / fatigue / myeloproliferative neoplasm / Non-small cell lung cancer / Polycythemia / essential thrombocythemia myelofibrosis / Infection / dizziness / Breast cancer / Pancreatic cancer / myelofibrosis / serious infection / lung cancers / high-risk myelofibrosis / / MedicalTreatment dialysis / / Organization FDA / / Person Srdan Verstovsek / Pamela M. Murphy / / / Position President and Chief Executive Officer / VP / Investor Relations and Corporate Communications / pharmacist for more information / / Product United States / / ProvinceOrState Delaware / / Technology dialysis / / URL www.incyte.com / www.jakafi.com / /
SocialTag |
THE DRIVE TO DISCOVER. THE EXPERIENCE TO DELIVER. October 2014 www.incyte.com